Myeloid Leukemias Terminated Phase 1 Trials for CC-401 (DB12432)

Back to Myeloid Leukemias

Also known as: Leukemia, Myeloid / Myeloid leukaemia / Myeloid Leukemia / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS

IndicationStatusPhase
DBCOND0042450 (Myeloid Leukemias)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00126893Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid LeukemiaTreatment